Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction
Conditions
- Non-ST Elevation Myocardial Infarction
Interventions
- DRUG: Tocilizumab 280 mg
- DRUG: NaCl 0.9% 100 ml
Sponsor
Oslo University Hospital
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]